[33] The reason this matters is that these bacteria are known to produce short-chain fatty acids (SCFAs), which increase insulin sensitivity and gastrointestinal function, while decreasing inflammation
These include but are likely not limited to chronic hyperglycemia, hypertension, dyslipidemia, obesity, insulin resistance, sodium retention, neurohormonal activation and low-grade inflammation, all related to the metabolic syndrome [9, 10]
Can wait for the next month
Design of acid-responsive polymeric nanoparticles for 7,3,4-trihydroxyisoflavone topical administration
Interestingly, inosine, a product of ADA activity was shown to be higher in levels in RA patients and the higher levels appear to reflect our biochemical data on increased ADA activity in the serum of RA patients